[HTML][HTML] Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy

…, P Niaudet, P Cochat, L Heidet, S Lebbah… - Kidney international, 2012 - Elsevier
Alport syndrome inevitably leads to end-stage renal disease and there are no therapies
known to improve outcome. Here we determined whether angiotensin-converting enzyme …

Low rate of daily smokers in patients with symptomatic COVID-19

…, C Morelot-Panzini, J Pernet, J Haroche, S Lebbah… - MedRxiv, 2020 - medrxiv.org
Background Identification of prognostic factors in COVID-19 remains a global challenge.
The role of smoking is still controversial. Objective To evaluate the rate of daily smokers in …

Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised …

S Gaudry, D Hajage, L Martin-Lefevre, S Lebbah… - The Lancet, 2021 - thelancet.com
Background Delaying renal replacement therapy (RRT) for some time in critically ill patients
with severe acute kidney injury and no severe complication is safe and allows optimisation …

Improving mutation screening in familial hematuric nephropathies through next generation sequencing

…, K Dahan, P Hilbert, M Lison, S Lebbah… - Journal of the …, 2014 - journals.lww.com
Alport syndrome is an inherited nephropathy associated with mutations in genes encoding
type IV collagen chains present in the glomerular basement membrane. COL4A5 mutations …

CKD and its risk factors among patients with cystinuria

C Prot-Bertoye, S Lebbah, M Daudon… - Clinical Journal of the …, 2015 - journals.lww.com
Results Median age at onset of symptoms was 16.7 (minimum to maximum, 0.3–72.1) years
and median diagnosis delay was 1.3 (0–45.7) years. Urinary alkalinization and cystine-…

Comprehensive PKD1 and PKD2 mutation analysis in prenatal autosomal dominant polycystic kidney disease

MP Audrézet, C Corbiere, S Lebbah… - Journal of the …, 2016 - journals.lww.com
Prenatal forms of autosomal dominant polycystic kidney disease (ADPKD) are rare but can
be recurrent in some families, suggesting a common genetic modifying background. Few …

[HTML][HTML] Characteristics, management, and prognosis of elderly patients with COVID-19 admitted in the ICU during the first wave: insights from the COVID-ICU study …

M Dres, D Hajage, S Lebbah, A Kimmoun, T Pham… - Annals of intensive …, 2021 - Springer
Background The COVID-19 pandemic is a heavy burden in terms of health care resources.
Future decision-making policies require consistent data on the management and prognosis …

Online information and support for carers of people with young‐onset dementia: A multi‐site randomised controlled pilot study

…, S Tezenas du Montcel, S Lebbah… - … Journal of Geriatric …, 2019 - Wiley Online Library
Objectives The European RHAPSODY project sought to develop and test an online
information and support programme for caregivers of individuals diagnosed with young onset …

[HTML][HTML] Effect of topiramate on eating behaviours in Prader-Willi syndrome: TOPRADER double-blind randomised placebo-controlled study

…, C Poitou, M Coupaye, G Pinto, S Lebbah… - Translational …, 2019 - nature.com
Prader–Willi Syndrome (PWS) is a rare genetic syndrome leading to severe behavioural
disorders and mild cognitive impairment. The objective of this double-blind randomised placebo…

[HTML][HTML] Lower rate of daily smokers with symptomatic COVID-19: a monocentric self-report of smoking habit study

…, J Pernet, J Haroche, S Lebbah… - Frontiers in …, 2022 - frontiersin.org
Background: Identification of prognostic factors in COVID-19 remains a global challenge.
The role of smoking is still controversial. Methods: PCR-positive in- and outpatients with …